Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases

This document is a response to comments regarding the LCD for genomic sequence analysis panels in the treatment of hematolymphoid diseases and announces the administrative timeline. The official notice period began on June 14, 2018 and the final LCD became effective for services rendered on or after August 1, 2018. No clinical coverage, limitation, documentation, or frequency criteria are specified in this response notice.

"Official notice period for the final LCD begins on 2018-06-14 and the final determination becomes effective for services rendered on or after 2018-08-01."

Sign up to see full coverage criteria, indications, and limitations.